SCHEMBL3850262

SCHEMBL3850262

CCOC(=O)c1ccc(B2OC(C)(C)C(C)(C)O2)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.46
CYP4A11 Q02928 1/20 0.46
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44
BAZ2B Q9UIF8 1/20 0.43
BAZ2A Q9UIF9 1/20 0.43
CA12 O43570 3/20 0.42
CA9 Q16790 3/20 0.42
AAK1 Q2M2I8 1/20 0.42
UCHL1 P09936 1/20 0.42
CA7 P43166 2/20 0.41
CA14 Q9ULX7 2/20 0.41
HIF1A Q16665 2/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.39
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM3 P20309 1/20 0.39
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4513021 0.91 CYP4F2 (0.53) CYP4F2CYP4A11CA1CA2BAZ2B
SCHEMBL2782538 0.89 CA1 (0.43) CYP4F2CYP4A11CA1CA2CA12
SCHEMBL4819962 0.85 HIF1A (0.44) CYP4F2CYP4A11CA1CA2CA12
SCHEMBL2792346 0.85 AAK1 (0.44) CA1CA2CA12CA9AAK1
SCHEMBL3845797 0.84 ROCK1 (0.46) CYP4F2CYP4A11CA1CA2CA12
SCHEMBL10184702 0.84 TSHR (0.42) CYP4F2CYP4A11CA1CA2CA12
SCHEMBL5064664 0.83 UCHL1 (0.43) CA1CA2CA12CA9UCHL1
SCHEMBL22408213 0.83 HIF1A (0.45) CYP4F2CYP4A11CA1CA2CA12
SCHEMBL14929238 0.83 CA1 (0.56) CA1CA2CA12CA9UCHL1
SCHEMBL4817008 0.82 HIF1A (0.40) CYP4F2CYP4A11CA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed